Related Experiment Video

Updated: Aug 17, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

Up-regulation of EphB4 in mesothelioma and its biological significance

Guangbin Xia1, S Ram Kumar, Rizwan Masood

  • 1Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90033-9172, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|June 17, 2005
PubMed
Abstract

Insights

EphB4 receptor tyrosine kinase is highly expressed in mesothelioma, promoting cancer cell survival and growth. Targeting EphB4 offers a promising new therapeutic strategy for this rare cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Mesothelioma is a rare, aggressive cancer with limited treatment options.
  • Current therapies offer poor survival rates, necessitating novel therapeutic targets.

Purpose of the Study:

  • To investigate the role of EphB4 receptor tyrosine kinase in mesothelioma.
  • To identify EphB4 as a potential diagnostic, prognostic, and therapeutic target.

Main Methods:

  • Studied EphB4 expression and function in mesothelioma cell lines and a murine model.
  • Utilized small interfering RNA and antisense oligodeoxynucleotides for EphB4 knockdown.
  • Analyzed apoptosis, cell survival, migration, invasion, and signaling pathways (Akt, bcl-xl).

Main Results:

  • EphB4 was highly expressed in mesothelioma cells and tumors, but not normal mesothelium.
  • EphB4 knockdown reduced cell survival, migration, invasion, and induced apoptosis.
  • Inhibition of EphB4 decreased tumor growth, cell division, and microvascular density in vivo.

Conclusions:

  • EphB4 is upregulated in mesothelioma and contributes to tumor cell survival.
  • EphB4 represents a potential novel therapeutic target for mesothelioma treatment.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...